1、 PARK J H,PEYRIN-BIROULET L,EISENHUT M,et al.IBD immunopathogenesis:A comprehensive review of inflammatory molecules[J].Autoimmun Rev,2017,16(4):416-426. PARK J H,PEYRIN-BIROULET L,EISENHUT M,et al.IBD immunopathogenesis:A comprehensive review of inflammatory molecules[J].Autoimmun Rev,2017,16(4):416-426.
2、 de SOUZA H S,FIOCCHI C.Immunopathogenesis of IBD:current state of the art[J].Nat Rev Gastroenterol Hepatol,2016,13(1):13-27. de SOUZA H S,FIOCCHI C.Immunopathogenesis of IBD:current state of the art[J].Nat Rev Gastroenterol Hepatol,2016,13(1):13-27.
3、 罗丹,高路,仝战旗,等.五味苦参肠溶胶囊对溃疡性结肠炎小鼠半胱天冬氨酸蛋白酶1、白细胞介素-1β蛋白的影响[J].解放军医学院学报,2018,39(2):140-143,149. 罗丹,高路,仝战旗,等.五味苦参肠溶胶囊对溃疡性结肠炎小鼠半胱天冬氨酸蛋白酶1、白细胞介素-1β蛋白的影响[J].解放军医学院学报,2018,39(2):140-143,149.
4、 罗丹,高路,仝战旗,等.五味苦参肠溶胶囊对溃疡性结肠炎小鼠炎性因子的影响[J].中华中医药杂志,2018,33(10):4719-4722. 罗丹,高路,仝战旗,等.五味苦参肠溶胶囊对溃疡性结肠炎小鼠炎性因子的影响[J].中华中医药杂志,2018,33(10):4719-4722.
5、 刁凌云,王胜英,皇金萍,等.美沙拉秦缓释颗粒剂联合五味苦参肠溶胶囊治疗溃疡性结肠炎的疗效观察[J].包头医学院学报,2021,37(10):43-48. 刁凌云,王胜英,皇金萍,等.美沙拉秦缓释颗粒剂联合五味苦参肠溶胶囊治疗溃疡性结肠炎的疗效观察[J].包头医学院学报,2021,37(10):43-48.
6、 仝战旗,杨波,童新元,等.复方苦参结肠溶胶囊治疗湿热内蕴型溃疡性结肠炎多中心、随机、双盲、对照研究[J].中国中西医结合杂志,2011,31(2):172-176. 仝战旗,杨波,童新元,等.复方苦参结肠溶胶囊治疗湿热内蕴型溃疡性结肠炎多中心、随机、双盲、对照研究[J].中国中西医结合杂志,2011,31(2):172-176.
7、 赵军. 复方苦参结肠溶胶囊治疗溃疡性结肠炎湿热内蕴证的临床研究[J].中国中医药现代远程教育,2017,15(13):48-49. 赵军. 复方苦参结肠溶胶囊治疗溃疡性结肠炎湿热内蕴证的临床研究[J].中国中医药现代远程教育,2017,15(13):48-49.
8、 HOU W B,SUN W J,ZHANG X W,et al.Five-Flavor sophora flavescens enteric-coated capsules for ulcerative colitis:A Systematic review and meta-analysis of randomized clinical trials[J].Evid Based Complement Alternat Med,2022(2022):9633048. HOU W B,SUN W J,ZHANG X W,et al.Five-Flavor sophora flavescens enteric-coated capsules for ulcerative colitis:A Systematic review and meta-analysis of randomized clinical trials[J].Evid Based Complement Alternat Med,2022(2022):9633048.
9、 NARULA N,MARSHALL J K,COLOMBEL J F,et al.Systematic review and meta-Analysis:Infliximab or cyclosporine as rescue therapy in patients with severe ulcerative colitis refractory to steroids[J].Am J Gastroenterol,2016,111(4):477-491. NARULA N,MARSHALL J K,COLOMBEL J F,et al.Systematic review and meta-Analysis:Infliximab or cyclosporine as rescue therapy in patients with severe ulcerative colitis refractory to steroids[J].Am J Gastroenterol,2016,111(4):477-491.
10、 PIOVANI D,DANESE S,PEYRIN-BIROULET L,et al.Environmental risk factors for inflammatory bowel diseases:An umbrella review of meta-analyses[J].Gastroenterology,2019,157(3):647-659. PIOVANI D,DANESE S,PEYRIN-BIROULET L,et al.Environmental risk factors for inflammatory bowel diseases:An umbrella review of meta-analyses[J].Gastroenterology,2019,157(3):647-659.
11、 MICHIELAN A,D'INCà R.Intestinal permeability in inflammatory bowel disease:pathogenesis,clinical evaluation,and therapy of leaky gut[J].Mediators Inflamm,2015(2015):628157. MICHIELAN A,D'INCà R.Intestinal permeability in inflammatory bowel disease:pathogenesis,clinical evaluation,and therapy of leaky gut[J].Mediators Inflamm,2015(2015):628157.
12、 HUANG H,FANG M,JOSTINS L,et al.Fine-mapping inflammatory bowel disease loci to single-variant resolution[J].Nature,2017,547(7662):173-178. HUANG H,FANG M,JOSTINS L,et al.Fine-mapping inflammatory bowel disease loci to single-variant resolution[J].Nature,2017,547(7662):173-178.
13、 LLOYD-PRICE J,ARZE C,ANANTHAKRISHNAN A N,et al.Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases[J].Nature,2019,569(7758):655-662. LLOYD-PRICE J,ARZE C,ANANTHAKRISHNAN A N,et al.Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases[J].Nature,2019,569(7758):655-662.
14、 FELDMAN G J,MULLIN J M,RYAN M P.Occludin:structure,function and regulation[J].Adv Drug Deliv Rev,2005,57(6):883-917. FELDMAN G J,MULLIN J M,RYAN M P.Occludin:structure,function and regulation[J].Adv Drug Deliv Rev,2005,57(6):883-917.
15、 KUO W T,ZUO L,ODENWALD M A,et al.The tight junction protein ZO-1 is dispensable for barrier function but critical for effective mucosal repair[J].Gastroenterology,2021,161(6):1924-1939. KUO W T,ZUO L,ODENWALD M A,et al.The tight junction protein ZO-1 is dispensable for barrier function but critical for effective mucosal repair[J].Gastroenterology,2021,161(6):1924-1939.
16、 SUNUWAR L,MEDINI M,COHEN L,et al.Correction to‘The zinc sensing receptor,ZnR/GPR39,triggers metabotropic calcium signalling in colonocytes and regulates occludin recovery in experimental colitis’[J].Philos Trans R Soc Lond B Biol Sci,2016,371(1703):20160331. SUNUWAR L,MEDINI M,COHEN L,et al.Correction to‘The zinc sensing receptor,ZnR/GPR39,triggers metabotropic calcium signalling in colonocytes and regulates occludin recovery in experimental colitis’[J].Philos Trans R Soc Lond B Biol Sci,2016,371(1703):20160331.
17、 Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers[R].U.S.Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers[R].U.S.Food & Drug Administration,2005. Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers[R].U.S.Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers[R].U.S.Food & Drug Administration,2005.
18、 WIRTZ S,POPP V,KINDERMANN M,et al.Chemically induced mouse models of acute and chronic intestinal inflammation[J].Nat Protoc,2017,12(7):1295-1309. WIRTZ S,POPP V,KINDERMANN M,et al.Chemically induced mouse models of acute and chronic intestinal inflammation[J].Nat Protoc,2017,12(7):1295-1309.
19、 刘海燕,陈军贤,徐平珍,等.复方苦参结肠溶胶囊治疗溃疡性结肠炎24例[J].中国中西医结合消化杂志,2012,20(2):86-88. 刘海燕,陈军贤,徐平珍,等.复方苦参结肠溶胶囊治疗溃疡性结肠炎24例[J].中国中西医结合消化杂志,2012,20(2):86-88.
20、 焦英伟,刘强,余兆惠.复方苦参结肠溶胶囊联合美沙拉嗪对改善溃疡性结肠炎患者生活质量的临床研究[J].山西医药杂志,2019,48(23):2932-2934. 焦英伟,刘强,余兆惠.复方苦参结肠溶胶囊联合美沙拉嗪对改善溃疡性结肠炎患者生活质量的临床研究[J].山西医药杂志,2019,48(23):2932-2934.
21、 TONG Z Q,YANG B,CHEN B Y,et al.A multi-center,randomized,single-blind,controlled clinical study on the efficacy of composite sophora colon-soluble capsules in treating ulcerative colitis[J].Chin J Integr Med,2010,16(6):486-492. TONG Z Q,YANG B,CHEN B Y,et al.A multi-center,randomized,single-blind,controlled clinical study on the efficacy of composite sophora colon-soluble capsules in treating ulcerative colitis[J].Chin J Integr Med,2010,16(6):486-492.
22、 钱家鸣,杨红.中国炎症性肠病研究的历史回顾现状和展望[J].中国实用内科杂志,2015,35(09):727-730. 钱家鸣,杨红.中国炎症性肠病研究的历史回顾现状和展望[J].中国实用内科杂志,2015,35(09):727-730.
23、 梁笑楠,尹凤荣,张晓岚.炎症性肠病诊断与治疗的共识意见(2018年,北京)溃疡性结肠炎部分解读[J].临床荟萃,2018,33(11):987-990. 梁笑楠,尹凤荣,张晓岚.炎症性肠病诊断与治疗的共识意见(2018年,北京)溃疡性结肠炎部分解读[J].临床荟萃,2018,33(11):987-990.
